← Back to Patent Explorer
US5387510A Expired / Lapsed US ⏱️ 0.0 years remaining

Detection of amplified nucleic acid using secondary capture oligonucleotides and test kit

Assignee: Clinical Diagnostic Systems Inc
•
Filing: 1991-10-02
•
Granted: 1995-02-07
•
Expires: 2011-10-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A target nucleic acid can be amplified and detected using a water-insoluble capture probe having a short oligonucleotide (15-20 nucleotides) covalently attached to a polymeric particle, and one or more secondary oligonucleotides. The capture probe and secondary oligonucleotides are complementary to the target nucleic acid, although the sequences of complementarity are different. Moreover, each of the secondary oligonucleotides has a length which is equal to or greater than the length of the capture probe oligonucleotide. The secondary oligonucleotides are hybridized to the target nucleic acid either before or during hybridization of the target to the capture probe. The result is improved hybridization efficiency of capture probe and target nucleic acid.

Inventors

  • 👤 Annie L. Wu

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 17:30
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6832; Y; Y10; Y10S; Y10S435/00; Y10S435/81

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 267 words
A method for amplification and detection of a double-stranded nucleic acid comprising: A. after denaturation of a target double-stranded nucleic acid, amplifying said target nucleic acid using a thermostable DNA polymerase, complementary primers and dNTPs, B. forming a water-insoluble hybridization product of said amplified target nucleic acid with a water-insoluble capture probe which is not detectably labeled, said capture probe comprising a water-insoluble polymeric particle to which is covalently attached an oligonucleotide complementary and specific to a first sequence of said amplified target nucleic acid, said oligonucleotide being from 15 to 20 nucleotides in length, and simultaneously or prior to said product formation, contacting said amplified target nucleic acid with one or more water-soluble, unlabeled, distinct secondary oligonucleotides, each of said secondary oligonucleotides being complementary and specific to a sequence of said amplified target nucleic acid other than said first sequence, and each of said secondary oligonucleotides having a length which is equal to or greater than the length of said capture probe oligonucleotide, to hybridize said secondary oligonucleotides with said amplified target nucleic acid, and C. detecting the resulting hybridized product formed from said amplified target nucleic acid and said water-insoluble capture probe, said detection being accomplished in one of the following ways: 1) using a a detectably labeled detection probe which is commlementary and specific to said amplified target nucleic acid in a region thereof other than to which said capture probe and second secondary oligonucleotides hybridize, 2) using at least one detectably primer as one of said complementary primers in amplification stem A), or 3) using a detectably labeled dNTP in amplification Step A).
Claim 2
Independent Claim 267 words
A method for amplification and detection of a double-stranded nucleic acid comprising: A. after denaturation of a target double-stranded nucleic acid, amplifying said target nucleic acid using a thermostable DNA polymerase, complementary primers and dNTPs, B. forming a water-insoluble hybridization product of said amplified target nucleic acid with a water-insoluble capture probe which is not detectably labeled, said capture probe comprising a water-insoluble polymeric particle to which is covalently attached an oligonucleotide complementary and specific to a first sequence of said amplified target nucleic acid, said oligonucleotide being from 15 to 20 nucleotides in length, and simultaneously or prior to said product formation, contacting said amplified target nucleic acid with one or more water-soluble, unlabeled, distinct secondary oligonucleotides, each of said secondary oligonucleotides being complementary and specific to a sequence of said amplified target nucleic acid other than said first sequence, and each of said secondary oligonucleotides having a length which is equal to or greater than the length of said capture probe oligonucleotide, to hybridize said secondary oligonucleotides with said amplified target nucleic acid, and C. detecting the resulting hybridized product formed from said amplified target nucleic acid and said water-insoluble capture probe, said detection being accomplished in one of the following ways: 1) using a a detectably labeled detection probe which is commlementary and specific to said amplified target nucleic acid in a region thereof other than to which said capture probe and second secondary oligonucleotides hybridize, 2) using at least one detectably primer as one of said complementary primers in amplification stem A), or 3) using a detectably labeled dNTP in amplification Step A).
Claim 3
Dependent Claim 22 words
The method of claim 1 wherein said amplified target nucleic acid is contacted with said capture probe and said secondary oligonucleotides simultaneously.
Claim 4
Dependent Claim 23 words
The method of claim 1 wherein the concentration of said secondary oligonucleotides is about the same as that of said capture probe oligonucleotide.
Claim 5
Dependent Claim 28 words
The method of claim 1 wherein each hybridization is carried out at a temperature of from about 40° to about 45° C. for at least about 5 minutes.
Claim 6
Dependent Claim 16 words
The method of claim 1 wherein said target nucleic acid is less than 250-mer in length.
Claim 7
Dependent Claim 42 words
The method of claim 1 wherein said hybridized product is detect using a detection probe which is complementary and spsecific to said amplified target nucleic acid in a region thereof other than to which said capture probe and second secondary oligonucleotides hydridize.
Claim 8
Dependent Claim 21 words
The method of claim 1 wherein at least one of said primers is detectably labeled for detection of said hybridized product.
Claim 9
Dependent Claim 26 words
The method of claim 1 wherein said hybridized product is detected using a detection probe which is complementary and specific to one of said secondary oligonucleotides.
Claim 10
Dependent Claim 30 words
The method of claim 1 wherein amplification is achieved using a thermostable DNA polymerase isolated from a Thermus species, or a recombinant equivalent thereof, and at least 20 amplification cycles.
Claim 11
Dependent Claim 41 words
The method of claim 1 wherein said capture probe is immobilized on a substrate selected from the group consisting of a microporous filtration membrane, a polymeric film and a resin-coated paper, and detection of said hybridized product occurs on said substrate.
Claim 12
Dependent Claim 154 words
A kit for a combined process of the amplification and detection of a target nucleic acid consisting essentially of, in individual packaging: a. a water-insoluble capture probe which is not detectably labeled and which comprises a water-insoluble polymeric particle to which is covalently attached an oligonucleotide complementary to a first sequence of said target nucleic acid, said oligonucleotide being from 15 to 20 nucleotides in length, b. one or more water-soluble, unlabeled, distinct secondary oligonucleotides, each of said secondary oligonucleotides, each of said secondary oligonucleotides being complementary and specific to a sequence of said target nucleic acid other than said first sequence, and each of said secondary oligonucleotides having a length which is equal to or greater than the length of said capture probe oligonucleotide, c. primers specific for said amplified target nucleic acid, d. a thermostable DNA polymerase, and e. dNTP's, wherein either one of said primers or said dNTP's is detectably labeled.
Claim 13
Dependent Claim 154 words
A kit for a combined process of the amplification and detection of a target nucleic acid consisting essentially of, in individual packaging: a. a water-insoluble capture probe which is not detectably labeled and which comprises a water-insoluble polymeric particle to which is covalently attached an oligonucleotide complementary to a first sequence of said target nucleic acid, said oligonucleotide being from 15 to 20 nucleotides in length, b. one or more water-soluble, unlabeled, distinct secondary oligonucleotides, each of said secondary oligonucleotides, each of said secondary oligonucleotides being complementary and specific to a sequence of said target nucleic acid other than said first sequence, and each of said secondary oligonucleotides having a length which is equal to or greater than the length of said capture probe oligonucleotide, c. primers specific for said amplified target nucleic acid, d. a thermostable DNA polymerase, and e. dNTP's, wherein either one of said primers or said dNTP's is detectably labeled.
Claim 14
Dependent Claim 20 words
The kit of claim 11 wherein said particles have an average diameter of from about 0.1 to about 10 μmeters.
Claim 15
Dependent Claim 31 words
The kit of claim 11 wherein said capture probe oligonucleotide is from about 15-mer to about 20mer, and each of said secondary oligonucleotides is independently from about 15-mer to about 35-mer.
Claim 16
Dependent Claim 15 words
The kit of claim 11 further including a disposable test device comprising a microporous membrane.
Claim 17
Dependent Claim 15 words
The kit of claim 14 wherein said capture probe is immobilized on said microporous membrane.
Claim 18
Dependent Claim 15 words
The kit of claim 1 wherein at least one of said primers is detectably labeled.
Claim 19
Dependent Claim 51 words
The kit of claim 16 wherein at least one of said primers is detectably labeled with biotin, and said kit further includes a composition for providing a colorimetric or chemiluminescent signal upon reaction with biotin, said composition comprising avidin conjugated with a detectable label which provides a colorimetric or chemluminescent signal.

References Cited (Backward Citations)

US4755458A Cited
US4965188A Cited
US5079351A Cited
GB2202328A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-02-06 1998-08-08 1999-02-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-02-06 2002-08-08 2003-02-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-02-06 2006-08-08 2007-02-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag